Why Farbe Firma is the Leading Injectable Manufacturer in Saint Lucia
Why Farbe Firma is the Leading Injectable Manufacturer in Saint Lucia
Last Updated: 19 September 2026
TL;DR: Saint Lucia has no product registration regime to file into. The Pharmacy Act registers pharmacists, pharmacies and sellers of poisons, not medicines, and the Ministry of Health's own profile with PAHO records marketing authorisation and import control as functions the country does not perform. There is therefore no recognition list and no dossier to win. The gate that decides public-sector volume is the OECS Pharmaceutical Procurement Service in Castries, whose prequalification asks for a GMP or ISO certificate and names no issuing authority.
Key Takeaways
The whole medicines statute is the Pharmacy Act, Cap. 11.21, enacted as Act 8 of 2003 and in force from 1 April 2003, with the Pharmacy (Forms and Fees) Regulations 2006 and the Pharmacy Regulations 2007 beneath it. All three are commenced, and on the face of the law as revised to 31 December 2022 the things they register are persons and premises.
The absence of a product register is a proven absence rather than a gap in our searching. The joint Ministry of Health and PAHO pharmaceutical country profile states that legal provisions do not require marketing authorisation for pharmaceutical products on the market. That profile is dated January 2012, so read it as establishing the legal architecture, not today's administrative practice.
Because there is no list of recognised reference authorities, asking whether India's CDSCO appears on one is a category error. CARPHA's regional system does publish such a list and India is absent from it, but Saint Lucia is not among the six CARICOM states with a legal marketing-authorisation requirement in the first place.
The operative gate is the OECS Pharmaceutical Procurement Service, which the Pharmacy Act expressly carves out of the Pharmacy Council's remit. Its manufacturer prequalification form asks whether you hold GMP or ISO certification and names no issuing authority, and Indian manufacturers bid into those tenders in their own right.
Introduction: What an Injectable Manufacturer in Saint Lucia Actually Has to Clear
Most country guides for exporters begin by explaining how to register a product, and in Saint Lucia that framing fails immediately, because there is nothing to register with. Even the size of the market is contested: the World Bank gives 179,744 people for 2024 while the Central Statistical Office's 2022 census counted 172,948. We are not choosing between those figures, and a supplier building a volume forecast should not quietly choose either.
The governing instrument is the Pharmacy Act, Cap. 11.21, which establishes a Pharmacy Council that registers pharmacists, pharmacies and authorised sellers of poisons. Its two subsidiary instruments deal with forms, fees, premises standards, storage and dispensing. None of the three creates a product register. Note what that does not mean: Saint Lucia is not an unregulated market. It has a pharmacy profession, licensed premises, a dispensing classification, poisons control and inspectors. What it lacks is product authorisation.
What Sets a World-Class Injectable Manufacturer in Saint Lucia Apart
What distinguishes a serious supplier is refusing to read an empty register as an open door. There is no marketing authorisation to obtain, which also means there is no regulatory asset to hold: no certificate, no data exclusivity, nothing to stop the next supplier following you in a month later. The absence of a registration procedure removes your cost of entry and your competitive moat in the same stroke, and it is not an affirmative legal permission to import.
The second discipline is refusing to convert silence into a rule. Pharmaceuticals are not named in Saint Lucia's import-licensing schedules as notified to the WTO, but two catch-all entries sit in those schedules and we could not establish how they are applied to medicines in practice. So we will tell you what the schedules say and decline to tell you what happens at the wharf.
Quality Systems Behind Every Batch Shipped to Saint Lucia
Farbe Firma manufactures sterile injectables under WHO-GMP certification with ISO Class 5 aseptic filling in Gujarat, India, supported by in-house HPLC, GC, LAL endotoxin and Karl Fischer testing and ICH Q1A and Q1B stability programmes. Every batch ships with a certificate of analysis traceable to retained samples, and we prepare CTD and ACTD dossiers for the 30+ countries we export to. Here that documentation is not a filing requirement. It is the only independent quality evidence anyone in the chain will hold.
That matters more here than in a market with a regulator to lean on. The 2012 profile records that Saint Lucia has no national quality control laboratory, no authority issuing good distribution practice licences and no manufacturers of its own. Where the state does not test what arrives, the manufacturer's analytical record is the whole of the assurance, and cold-chain integrity becomes a risk you carry rather than one an inspector catches.
Why Farbe Firma is the Trusted Injectable Manufacturer in Saint Lucia for Global Buyers
The commercially useful fact is that the real gate is regional, not national. The Pharmacy Act provides that it shall not be construed as giving the Pharmacy Council responsibility over any activity for which the Pharmaceutical Procurement Service is responsible, and that Service is headquartered in Castries. Public procurement across the OECS is pooled through it, and suppliers must be prequalified and listed in its directory before they can bid.
What that prequalification asks for is the part worth reading closely. The guidance requires products to meet WHO Good Manufacturing, Storage and Distribution Practice. The manufacturer form asks whether the company holds GMP certification, ISO certification or other, and says to attach the certificate. It names no issuing authority and publishes no list of trusted regulators. A WHO-GMP certificate from an Indian state licensing authority answers the question that form asks.
The door has demonstrably been open. The most recent award schedule we could locate, covering 2015 to 2017, shows India-manufactured sterile injectables awarded across the pooled tender, among them bupivacaine, cefotaxime, amiodarone, labetalol, naloxone and iron sucrose. Indian manufacturers including Hetero Labs appear in the current cycles as opened and fully accepted for evaluation, which is bid admissibility and not an award; outcomes are unpublished, and we will not dress one up as the other.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Do I need to register my injectable before it can be sold in Saint Lucia?
There is no product registration procedure to enter. The Ministry of Health and PAHO country profile records that legal provisions do not require marketing authorisation for products on the market, and the Pharmacy Act as revised to 31 December 2022 adds none. Two cautions. That profile is dated January 2012, so it establishes the legal architecture rather than current practice. And no register is not permission to import: your counterparty, the border and any tender remain live gates.
Is India's CDSCO on a recognised or reference authority list?
The question is a category error here and we would rather say so than give a tidy yes or no. No Saint Lucian instrument we located names any foreign regulator at all, whether the US FDA, the EMA or CDSCO, because there is no reliance procedure for such a list to attach to. CDSCO is neither on a Saint Lucian list nor excluded from one, since exclusion presupposes a list.
What are the registration fees and review timelines?
There are none, because there is no product registration to charge for or to time. Any guide quoting a figure for Saint Lucia should be treated with suspicion. The fees that do exist under the Pharmacy (Forms and Fees) Regulations 2006 attach to pharmacists, sellers and premises rather than to products, and the one-year validity in the Act likewise attaches to a person's or premises' certificate, not to a product.
Who actually buys, and do I need a local counterparty?
Public-sector demand is pooled through the OECS Pharmaceutical Procurement Service in Castries, and the private channel runs through registered pharmacies and authorised sellers of poisons. Two routes into the OECS directory are visible in the published documents: a manufacturer may prequalify in its own right, or a prequalified distributor may carry you with letters of authorisation. In the 2015 to 2017 award list the contracting supplier is usually a regional distributor with the Indian firm named in the manufacturer column.
What clinical demand should an injectables supplier actually plan for?
A non-communicable disease profile. PAHO puts noncommunicable diseases at 82.1 per cent of deaths in 2019, with cardiovascular disease, diabetes and cancer leading, against adult hypertension of 27.1 per cent in 2015 and diabetes of 14.5 per cent in 2014. The population aged 65 and over is projected to rise from about a tenth in 2020 to 29.6 per cent by 2060, the fastest such rise in the Caribbean.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments